1Maruvada R, Zhu L, Pearce D, et al. Cryptococcus neoformans phospholipase B1 activates host cell Racl for traversal across the blood-brain barrier[ J ]. Cell Microbiol, 2012,14 ( 10 ) : 1544- 1553.
2Chang YC, Stins MF, McCaffery M J, et al. Cryptococcal yeast cells invade the central nervous system via transcellular penetra- tion of the blood-brain barrier[ J ]. Infect Immun,2004,72 (9) : 4985-4995.
3Kim JC, Crary B, Chang YC, et al. Cryptococcus neoformans activates RhoGTPase proteins followed by protein kinase C, focal adhesion kinase, and ezrin to promote traversal across the blood- brain barrier[ J]. J Biol Chem,2012,287 (43) :36147-36157.
4Stie J, Fox D. Induction of Brain Mierovaseular Endothelial Cell Urokinase Expression by Cryptococcus neoformans Facilitates Blood-Brain Barrier Invasion [ J]. PLoS One, 2012,7 ( 11 ) : e49402.
5Stie J, Fox D. Blood-brain barrier invasion by Cryptococcns neoformans is enhanced by functional interactions with plasmin [ J]. Microbiology ,2012,158 ( Pt 1 ) :240-258.
6Vu K, Weksler B, Romero I, et al. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infec- tion by Cryptococcus neoformans [ J ]. Eukaryot Cell, 2009,8 (11) : 1803-1807.
7Huppert J, Closhen D, Croxford A, et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption [ J ]. FASEB J, 2010,24(4) : 1023-1034.
8Nakagawa S, Deli MA, Kawaguchi H, et al. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes[ J]. Neurochem Int, 2009,54 ( 3-4 ) :253-263.
9Carline C, Kirsten N, Samira D, et al. Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans [ J ]. Infect Immun ,2009,77 ( 1 ) : 120 -127.
10Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier [ J ]. Trends Neurosci ,2001,24(12) :719-725.
4BenaducciT, MatsumotoMT, SardiJC, et al. A flow cytometry method for testing the susceptibility of Cryptococcus spp. to amphotericin B[J]. Rev Iberoam Micol, 2014, pii:S1130-1406(14): 00071-00077.
5JarvisJN, BicanicT, LoyseA, et al. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes[J]. Clin Infect Dis, 2014, 58(5):736–745.
6FangW, FaZ, LiaoW. Epidemiology of Cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015, 78:7–15.
